In the fast-paced realm of drug discovery, Molecule GEN stands as a beacon of innovation, promising a quantum leap in the way we approach pharmaceutical br...
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in r...
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...
- Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a sca...
Wipro Limited a leading technology services and consulting company, today announced a collaboration with NVIDIA to help healthcare companies accelera...
Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...
“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exacte...
The SOPHIE program supports collaborative projects for Ontario-based life science firms in the later stages of commercialization. DiagnaMed can leverage fu...
Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an eq...
Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in ...
BioPhy launched its AI operating system that radically accelerates the identification and development of the most promising drug candidates. By combi...
In a rapidly evolving world where data and artificial intelligence have become paramount, BioAsia 2024 presents a theme that transcends traditional boundar...
Founded in 2002, ConcentricLife is recognized as one of the MM+M Agency 100, the industry's definitive guide to the top agencies in the health landscape. I...
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to con...
© 2023 Biopharma Boardroom. All Rights Reserved.
